“Lynparzatm (olaparib): new medicine for targeted therapy of ovarian cancer” (2016) Onkologija, 20(1), pp. 12–14. Available at: https://www.revijaonkologija.si/Onkologija/article/view/60 (Accessed: 4 September 2026).